Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 26, 2023; 11(9): 1974-1984
Published online Mar 26, 2023. doi: 10.12998/wjcc.v11.i9.1974
Published online Mar 26, 2023. doi: 10.12998/wjcc.v11.i9.1974
Effects of individual shock wave therapy vs celecoxib on hip pain caused by femoral head necrosis
Jun-Yu Zhu, Geng-Yan Xing, Orthopedic Department, The Third Medical Center of Chinese People’s Liberation Army General Hospital, The Armed Police Clinical College, Anhui Medical University, Hefei 230022, Anhui Province, China
Jun-Yu Zhu, Jun Yan, Jian Xiao, Hai-Guang Jia, Hao-Jun Liang, Orthopedic Department, The Third Medical Center of Chinese People’s Liberation Army General Hospital, Beijing 100039, China
Author contributions: Xing GY designed this study; Yan J and Jia HG collected the data; Liang HJ analyzed the data; Zhu JY and Xiao J drafted the manuscript and gave final approval of the version to be published.
Institutional review board statement: The research protocol was approved by the Ethics Committee of The Third Medical Center of Chinese People’s Liberation Army General Hospital (ID: 001-R1).
Clinical trial registration statement: This study was registered on the Chinese Clinical Trial Registry (ChiCTR2100047844).
Informed consent statement: Informed written consent was obtained from the patients to publish this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Data sharing statement: The datasets used and/or analyzed in the current study are available from the corresponding author upon reasonable request.
CONSORT 2010 statement: The manuscript was prepared and revised according to the CONSORT 2010 statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Geng-Yan Xing, PhD, Additional Professor, Orthopedic Department, The Third Medical Center of Chinese People’s Liberation Army General Hospital, The Armed Police Clinical College, Anhui Medical University, No. 81 Meishan Road, Hefei 230022, Anhui Province, China. jyzhu@ihep.ac.cn
Received: November 19, 2022
Peer-review started: November 19, 2022
First decision: January 30, 2023
Revised: February 7, 2023
Accepted: March 3, 2023
Article in press: March 3, 2023
Published online: March 26, 2023
Processing time: 118 Days and 4.9 Hours
Peer-review started: November 19, 2022
First decision: January 30, 2023
Revised: February 7, 2023
Accepted: March 3, 2023
Article in press: March 3, 2023
Published online: March 26, 2023
Processing time: 118 Days and 4.9 Hours
Core Tip
Core Tip: This is a randomized, controlled, and non-inferiority trial. To the best of our knowledge, the present study is the first to investigate the short-term effectiveness of extracorporeal shock wave therapy (ESWT) in the management of osteonecrosis of the femoral head (ONFH). Traditional ESWT was innovated by magnetic resonance imaging three-dimensional (MRI-3D) reconstruction technology. The final results demonstrate that ESWT based on MRI-3D reconstruction is not inferior to celecoxib in treating hip discomfort and restrictions associated with ONFH.